Advertisement

Adaptation of Liver Stiffness Cutoff Values to Inflammation, Cholestasis, and Congestion

  • Sebastian MuellerEmail author
Chapter
  • 67 Downloads

Abstract

Liver stiffness (LS) is not only associated with fibrosis stage or matrix/collagen deposition but also many other clinical, cellular, and biophysical confounders. Most important clinical conditions that elevate LS include inflammation/hepatitis, congestion/elevated central venous pressure and mechanic cholestasis. Interestingly, steatosis is either not or even slightly negatively associated with LS, a fact that is still poorly understood. At the hemodynamic levels, LS elevation can be interpreted by the inflow/outflow balance model where both an increase of blood inflow either through portal vein or hepatic artery and an impaired outflow through hepatic veins or bile duct will increase LS. In clinical practice, these confounders often present in combination. Confounders of LS elevation are not only important for correct clinical interpretation of elevated LS, but also have a negative prognostic impact on fibrosis progression per se (see also sinusoidal pressure hypothesis). This chapter provides algorithms and practical hints to correctly interpret an elevated LS within the clinical context. An on-time abdominal ultrasound and actual laboratory parameters (namely AST levels) are most useful for a correct interpretation of LS.

Keywords

Fibrosis Cholestasis Steatosis Congestion Inflammation Noninvasive tests Transient elastography Biomarker 

References

  1. 1.
    Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008;48(5):1718–23.CrossRefGoogle Scholar
  2. 2.
    Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52(2):206–10.CrossRefGoogle Scholar
  3. 3.
    Lindvig K, Mossner BK, Pedersen C, Lillevang ST, Christensen PB. Liver stiffness and 30-day mortality in a cohort of patients admitted to hospital. Eur J Clin Investig. 2012;42(2):146–52.CrossRefGoogle Scholar
  4. 4.
    Mueller S. Personal observation. 2019.Google Scholar
  5. 5.
    Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2007;47(2):380–4.CrossRefGoogle Scholar
  6. 6.
    Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med. 2010;2:49–67.CrossRefGoogle Scholar
  7. 7.
    Mueller S, Englert S, Seitz HK, Badea RI, Erhardt A, Bozaari B, et al. Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease. Liver Int. 2015;35(12):2514–21.CrossRefGoogle Scholar
  8. 8.
    Arima Y, Kawabe N, Hashimoto S, Harata M, Nitta Y, Murao M, et al. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatol Res. 2010;40(4):383–92.CrossRefGoogle Scholar
  9. 9.
    Macias J, del Valle J, Rivero A, Mira JA, Camacho A, Merchante N, et al. Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin. J Antimicrob Chemother. 2010;65(10):2204–11.CrossRefGoogle Scholar
  10. 10.
    Wang J-H, Changchien C-S, Hung C-H, Tung W-C, Kee K-M, Chen C-H, et al. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: longitudinal study using FibroScan. J Gastroenterol Hepatol. 2010;25(5):964–9.CrossRefGoogle Scholar
  11. 11.
    Martinez SM, Foucher J, Combis J-M, Métivier S, Brunetto M, Capron D, et al. Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy. PLoS One. 2012;7(10):e47715.CrossRefGoogle Scholar
  12. 12.
    Stasi C, Arena U, Zignego AL, Corti G, Monti M, Triboli E, et al. Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. Dig Liver Dis. 2013;45(10):840–3.CrossRefGoogle Scholar
  13. 13.
    Elshaarawy O, Mueller J, Guha IN, Chalmers J, Harris R, Krag A, et al. Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications. JHEP Rep. 2019;1(2):99–106.CrossRefGoogle Scholar
  14. 14.
    Ogawa E, Furusyo N, Murata M, Ohnishi H, Toyoda K, Taniai H, et al. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog. Hepatol Res. 2011;41(12):1178–88.CrossRefGoogle Scholar
  15. 15.
    Stasi C, Salomoni E, Arena U, Corti G, Montalto P, Bartalesi F, et al. Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: a preliminary study. Eur J Pharmacol. 2017;806:105–9.CrossRefGoogle Scholar
  16. 16.
    Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, et al. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol. 2018;68(4):754–63.CrossRefGoogle Scholar
  17. 17.
    Nickel F, Tapking C, Benner L, Sollors J, Billeter AT, Kenngott HG, et al. Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year follow-up: BariScan study. Obes Surg. 2018;28(5):1342–50.CrossRefGoogle Scholar
  18. 18.
    Patel NS, Hooker J, Gonzalez M, Bhatt A, Nguyen P, Ramirez K, et al. Weight loss decreases magnetic resonance elastography estimated liver stiffness in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2017;15(3):463–4.CrossRefGoogle Scholar
  19. 19.
    Rausch V, Peccerella T, Lackner C, Yagmur E, Seitz HK, Longerich T, et al. Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M. World J Hepatol. 2016;8(35):1547–56.CrossRefGoogle Scholar
  20. 20.
    Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010;16(8):966–72.CrossRefGoogle Scholar
  21. 21.
    Trabut JB, Thepot V, Nalpas B, Lavielle B, Cosconea S, Corouge M, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res. 2012;36(8):1407–11.CrossRefGoogle Scholar
  22. 22.
    Mueller S, Luderer M, Zhang D, Meulien D, Steiniger Brach B, Brix Schou M. Open-Label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis’, Alcohol Alcohol. 2019; 55(2020):63–70.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Medicine and Center for Alcohol Research and Liver DiseasesSalem Medical Center, University of HeidelbergHeidelbergGermany

Personalised recommendations